Guardant Health Soars 17.2% on Q2 Earnings Beat

Guardant Health's stock surged 17.2% in pre-market trading on August 7, 2025, driven by strong financial performance and positive market sentiment.

Guardant Health reported robust financial results for the second quarter of 2025, with revenues exceeding expectations. The company's revenue growth was particularly noteworthy, increasing by 31% compared to the same period last year. This strong performance was highlighted during the Q2 2025 earnings call, where the company also raised its full-year sales guidance.

In addition to the revenue beat, Guardant Health's shares have been trading higher following the release of its Q2 financial results. The company's better-than-expected performance and raised guidance for the fiscal year 2025 have contributed to the positive market sentiment, driving the stock price upward.